Next Article in Journal
Only If You View It through a Different Lens
Previous Article in Journal
First Case of Sternum Replacement with a Bioceramic Prosthesis after Radio-Induced Sarcoma
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 25
Issue 4
10.3747/co.25.4233
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Erratum: Cost-Effectiveness of Everolimus for the Treatment of Advanced Neuroendocrine Tumours of Gastrointestinal or Lung Origin in Canada

by
A. Chua
1,*,
A. Perrin
1,
J.F. Ricci
2,
M.P. Neary
3 and
M. Thabane
4
1
Analytica Laser, New York, NY, USA
2
Wellmera AG, Basel, Switzerland
3
Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
4
Novartis Pharmaceuticals Corporation, Dorval, QC, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2018, 25(4), 354-355; https://doi.org/10.3747/co.25.4233
Submission received: 12 May 2018 / Revised: 9 June 2018 / Accepted: 2 July 2018 / Published: 1 August 2018

Abstract

In the initially submitted manuscript, two figures were included: [...]

Share and Cite

MDPI and ACS Style

Chua, A.; Perrin, A.; Ricci, J.F.; Neary, M.P.; Thabane, M. Erratum: Cost-Effectiveness of Everolimus for the Treatment of Advanced Neuroendocrine Tumours of Gastrointestinal or Lung Origin in Canada. Curr. Oncol. 2018, 25, 354-355. https://doi.org/10.3747/co.25.4233

AMA Style

Chua A, Perrin A, Ricci JF, Neary MP, Thabane M. Erratum: Cost-Effectiveness of Everolimus for the Treatment of Advanced Neuroendocrine Tumours of Gastrointestinal or Lung Origin in Canada. Current Oncology. 2018; 25(4):354-355. https://doi.org/10.3747/co.25.4233

Chicago/Turabian Style

Chua, A., A. Perrin, J.F. Ricci, M.P. Neary, and M. Thabane. 2018. "Erratum: Cost-Effectiveness of Everolimus for the Treatment of Advanced Neuroendocrine Tumours of Gastrointestinal or Lung Origin in Canada" Current Oncology 25, no. 4: 354-355. https://doi.org/10.3747/co.25.4233

APA Style

Chua, A., Perrin, A., Ricci, J. F., Neary, M. P., & Thabane, M. (2018). Erratum: Cost-Effectiveness of Everolimus for the Treatment of Advanced Neuroendocrine Tumours of Gastrointestinal or Lung Origin in Canada. Current Oncology, 25(4), 354-355. https://doi.org/10.3747/co.25.4233

Article Metrics

Back to TopTop